Key statistics
As of last trade Pharming Group NV (PHGUF:PKL) traded at 0.7547, 0.63% above its 52-week low of 0.75, set on Aug 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.7547 |
---|---|
High | 0.7547 |
Low | 0.7547 |
Bid | -- |
Offer | -- |
Previous close | 0.7547 |
Average volume | -- |
---|---|
Shares outstanding | 678.35m |
Free float | 662.48m |
P/E (TTM) | -- |
Market cap | 477.75m EUR |
EPS (TTM) | -0.0189 EUR |
Data delayed at least 15 minutes, as of Sep 04 2024 19:25 BST.
More ▼
Announcements
- Pharming Group to participate in September investor conferences
- Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
- Pharming Group reports second quarter and first half 2024 financial results and provides business update
- Pharming Group to report second quarter and first half 2024 financial results on August 1
- Pharming Group to participate in June investor conferences
- Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union
- Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
- Pharming Group to participate in May investor conference
- Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
- Pharming Group reports first quarter 2024 financial results and provides business update
More ▼